Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...